Anas Younes is a University Professor at the Weill-Cornell Medical College, and the acting Chief of Lymphoma Service at the Memorial Sloan Kettering Cancer Center, USA.
Professor Younes attended The University of Damascus School of Medicine, before going on to take his residencies at the Medical College of Ohio followed by the completion of his internal medicine residency at the SUNY Downstate Medical Center. He then completed his hematology-oncology fellowship at the Memorial Sloan Kettering Cancer Center. Following his fellowship, in 1992 Professor Younes moved over to the MD Anderson Cancer Centre before becoming the Chief of Lymphoma Service at the Memorial Sloan Kettering Cancer Center in 2013.
With particular interest in both Non-Hodgkin and Hodgkin Lymphoma, Professor Younes works closely with the development of novel targeted therapies for lymphoma, as well as the identification of biomarkers for treatment. He has been the Principal Investigator in over 60 clinical trials, including some of the pivotal trials around nivolumab and brentuximab vedotin in relapse/refractory Hodgkin Lymphoma; which resulted in FDA approvals.
Positions of responsibility/awards:
- Member of the Scientific Advisory Board of the Lymphoma Research Foundation
- Past Member of the National Cancer Institute Lymphoma Steering Committee
- Leader of the National Cancer Institute – funded SPORE (Specialized Programs of Research Excellence) in lymphoma both at MDACC (MD Anderson Cancer Center) and MSKCC (Memorial Sloan Kettering Cancer Center)
- Principal Investigator of a SCOR grant supported by the Leukemia and Lymphoma Society